Roivant Sciences (ROIV) Return on Capital Employed [ROCE] (2021 - 2026)
Roivant Sciences (ROIV) reported Return on Capital Employed [ROCE] of -11.41% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 11.75 percentage points from -23.16% a year earlier but down 1.48 percentage points from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Roivant Sciences posted Return on Capital Employed [ROCE] of -9.73%, up 6.50 percentage points from FY2025.
- Return on Capital Employed [ROCE] has a four-year change of +46.51 percentage points (FY2022 to FY2026).
- By fiscal year, Return on Capital Employed [ROCE] came in at -16.23% in FY2025 (-115.30 pp), 99.07% in FY2024 (+140.01 pp), -40.94% in FY2023 (+15.31 pp) and -56.25% in FY2022.
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -66.20% in fiscal Q2 2022 and a high of 105.12% in fiscal Q3 2024.
- Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -32.67 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q3 2024 (a gain of 166.59 percentage points); the low point was fiscal Q3 2025 (a drop of 120.91 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -9.93% (Q4 2026), -24.34% (Q3 2026) and -23.41% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Roivant Sciences | 25.81 Bn | 26.50 Bn | 1.16 Mn | -11.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.41% |
| Mar 31, 2026 | -9.93% |
| Dec 31, 2025 | -24.34% |
| Sep 30, 2025 | -23.41% |
| Jun 30, 2025 | -23.16% |
| Mar 31, 2025 | -18.36% |
| Dec 31, 2024 | -15.79% |
| Sep 30, 2024 | 77.25% |
| Jun 30, 2024 | 69.30% |
| Mar 31, 2024 | 63.28% |
| Dec 31, 2023 | 105.12% |
| Sep 30, 2023 | -45.44% |
| Jun 30, 2023 | -44.64% |
| Mar 31, 2023 | -44.80% |
| Dec 31, 2022 | -61.47% |
| Sep 30, 2022 | -49.42% |
| Jun 30, 2022 | -65.36% |
| Mar 31, 2022 | -53.90% |
| Dec 31, 2021 | -58.26% |
| Sep 30, 2021 | -66.20% |
API Access
Roivant Sciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();